Home » Newsletters » BioWorld Science

BioWorld Science

June 1, 1999

View Archived Issues

Sibia Neurosciences and Lilly enter collaboration for CNS disorders

Canadian university spins off new company to develop promising antibacterial agents

PathoGenesis signs European distribution agreements and launches TOBI in two new markets

NIAID-sponsored scientists on the way to developing a broad-spectrum staph vaccine

New perspectives for rFVIIa and rFVIIai

Remicade recommended for European approval by CPMP

Lamivudine to be launched in South Korea for hepatitis B

Phase II trial of York Medical's cancer vaccine cleared

Palatin Technologies prepares BLA for imaging agent

Additional phase II data suggest modifications for AVI BioPharma's cancer vaccine

Chinese scientists present new antiarrhythmic agent and effects on ischemia/reperfusion injury

Chinese scientists discover new MDR reversal agents during search for cardiovascular agents

New cholesterol-binding agent on the road to launch in Japan

Daiichi Pharmaceutical will market cevimeline in the U.S.

Chinese herbal remedy is safer and more effective than sildenafil in treating ED

Company Profile: ProtoMed

Carbapenems from Merck especially useful against resistant bacteria

Pfizer researchers present selective inhibitors of urokinase and their use

More on protein farnesyltransferase inhibitors in development at Merck

5-HT1A receptor agonists with good potency and selectivity designed at Pierre Fabre

Small study indicates therapeutic potential of sildenafil in women with sexual arousal disorders

Imidazole-based protein farnesyltransferase inhibitors for cancer

Novel class III antiarrhythmic agents synthesized at Merck

Novel matrix metalloproteinase inhibitor selectively inhibits rat osteosarcoma lung metastasis

Pharmacia & Upjohn's new treatment for ED in phase II testing; clinical results presented at AUA

Radiolabeled somatostatin analogue with potential for PET imaging and targeted radiotherapy

CGRP gene transfer successful and effective in rat model of pulmonary hypertension

Plant-derived compounds significantly reduce BP in hypertensive patients, SHRs

Hughes Institute publishes findings on anti-HIV agent active against resistant virus strains

Resubmission of ProMem NDA announced by Bayer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...